Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Triphosgene Mediated Acylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109988183A reveals a green synthesis route for DCC using triphosgene, eliminating DMAC solvent for reduced cost and higher purity in pharmaceutical manufacturing.
Patent CN107286078A details a safer pimavanserin route using triphosgene. This method ensures high purity and scalable production for reliable pharmaceutical intermediate supply chains.
Patent CN100569790C reveals a high-yield 3-step route for Capecitabine intermediates using triphosgene, offering significant cost reduction and scalability for pharmaceutical manufacturing.